Knowledge Hub

Pfizer Manufacturer: United States Anti-Obesity Drugs Market Research, New study, Growth Rate, Forecast Report 2017 (Prescription Drugs, OTC Drugs)

Press Release   •   Feb 02, 2017 02:10 EST

MarketResearchReports.Biz presents this most up-to-date research on "United States Anti-Obesity Drugs Market Report 2017"

Sales, means the sales volume of Anti-Obesity Drugs
Revenue, means the sales value of Anti-Obesity Drugs

This report studies sales (consumption) of Anti-Obesity Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Prescription Drugs
OTC Drugs

Split by applications, this report focuses on sales, market share and growth rate of Anti-Obesity Drugs in each application, can be divided into
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

Get The Sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/947395

Table of Contents

United States Anti-Obesity Drugs Market Report 2017
1 Anti-Obesity Drugs Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs
1.2.1 Prescription Drugs
1.2.2 OTC Drugs
1.3 Application of Anti-Obesity Drugs
1.3.1 6-18 Callant
1.3.2 18-30 Adult
1.3.3 30-60Middle-Aged
1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Anti-Obesity Drugs (2012-2022)
1.4.1 United States Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)

2 United States Anti-Obesity Drugs Competition by Manufacturers
2.1 United States Anti-Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti-Obesity Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti-Obesity Drugs Average Price by Manufactures (2015 and 2016)
2.4 Anti-Obesity Drugs Market Competitive Situation and Trends
2.4.1 Anti-Obesity Drugs Market Concentration Rate
2.4.2 Anti-Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Anti-Obesity Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Anti-Obesity Drugs Sales and Market Share by States (2012-2017)
3.2 United States Anti-Obesity Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Anti-Obesity Drugs Price by States (2012-2017)

Browse More Published Reports By Pharmaceutical Market Research: http://www.marketresearchreports.biz/category/38

4 United States Anti-Obesity Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Anti-Obesity Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Obesity Drugs Price by Type (2012-2017)
4.4 United States Anti-Obesity Drugs Sales Growth Rate by Type (2012-2017)

5 United States Anti-Obesity Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Anti-Obesity Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Obesity Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anti-Obesity Drugs Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Obesity Drugs Product Type, Application and Specification
6.1.2.1 Prescription Drugs
6.1.2.2 OTC Drugs
6.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Anti-Obesity Drugs Product Type, Application and Specification
6.2.2.1 Prescription Drugs
6.2.2.2 OTC Drugs
6.2.3 Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 F.Hoffmann-La Roche
6.3.2 Anti-Obesity Drugs Product Type, Application and Specification
6.3.2.1 Prescription Drugs
6.3.2.2 OTC Drugs
6.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Anti-Obesity Drugs Product Type, Application and Specification
6.4.2.1 Prescription Drugs
6.4.2.2 OTC Drugs
6.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Anti-Obesity Drugs Product Type, Application and Specification
6.5.2.1 Prescription Drugs
6.5.2.2 OTC Drugs
6.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
6.6.2 Anti-Obesity Drugs Product Type, Application and Specification
6.6.2.1 Prescription Drugs
6.6.2.2 OTC Drugs
6.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.2 Anti-Obesity Drugs Product Type, Application and Specification
6.7.2.1 Prescription Drugs
6.7.2.2 OTC Drugs
6.7.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eisai
6.8.2 Anti-Obesity Drugs Product Type, Application and Specification
6.8.2.1 Prescription Drugs
6.8.2.2 OTC Drugs
6.8.3 Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Norgine
6.9.2 Anti-Obesity Drugs Product Type, Application and Specification
6.9.2.1 Prescription Drugs
6.9.2.2 OTC Drugs
6.9.3 Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Arena Pharmaceuticals
6.10.2 Anti-Obesity Drugs Product Type, Application and Specification
6.10.2.1 Prescription Drugs
6.10.2.2 OTC Drugs
6.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Orexigen Therapeutics
6.12 Vivus
6.13 Alizyme
6.14 Rhythm Pharmaceuticals
6.15 Shionogi
6.16 Zafgan

7 Anti-Obesity Drugs Manufacturing Cost Analysis
7.1 Anti-Obesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Obesity Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Obesity Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Latest Industry Press Releases: http://www.marketresearchreports.biz/pressreleases

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E-Mail: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz
Thanks………..!!!!!!!!!!!